阿斯利康将携四项重磅研究首发数据亮相欧洲肿瘤内科学会年会

动脉网
Oct 14

欧洲肿瘤内科学会(ESMO)年会将于2025年10月17日至21日召开,阿斯利康将携逾95项摘要亮相,涵盖9款获批药物及9款潜在新药,包括2项入选重磅主席研讨会摘要及26项口头报告。关键研究亮点包括针对HER2阳性早期乳腺癌的DESTINY-Breast11和DESTINY-Breast05研究、针对三阴性乳腺癌的TROPION-Breast02研究,以及膀胱癌和胃癌领域的POTOMAC和...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10